Presbyopia Drops, a Promising Solution - Takeaways - MDSpire

Presbyopia Drops, a Promising Solution

While over-the-counter, prescription corrective lenses, and surgical interventions have been the mainstays of presbyopia management, presbyopia drops offer a non-invasive alternative.

  • By

  • Irene Zhou, BS, MS3

  • Ariana Rose Maleki, BS

  • Dagny Zhu, MD

  • April 1, 2025

  • 9 min

Share

  • 1

    Presbyopia drops, such as Vuity and Qlosi, offer a non-invasive alternative for managing near vision in patients over 40.

  • 2

    Clinical trials demonstrated that presbyopia drops significantly improve near vision while preserving distance vision, even in low-light conditions.

  • 3

    Careful patient selection and education are crucial for optimal outcomes, particularly for motivated individuals aged 40 to 50 with early to moderate presbyopia.

  • 4

    The FDA approved a twice-daily dosing option for Vuity in 2023, extending its effectiveness from 6 to 9 hours.

  • 5

    Common side effects of presbyopia drops include headaches and eye irritation, emphasizing the importance of patient counseling and adherence.

Original Source(s)

Presbyopia Drops, a Promising Solution

  • by Irene Zhou, BS, MS3, Ariana Rose Maleki, BS, Dagny Zhu, MD

  • April 1, 2025

Related Content

Multifocal Mythbusting

Concerns about chair time, adaptation issues, and inconsistent vision are rooted in outdated perceptions shaped by earlier generations of lenses and overshadow the many benefits that multifocal contact lenses can offer patients who have presbyopia.

FDA Approves TECNIS PureSee IOL for Cataract Surgery

First FDA-approved extended depth of focus (EDOF) IOL maintaining contrast sensitivity comparable to an aspheric monofocal IOL

  • March 23, 2026

  • 2 min
Presbyopia Solutions for Patients With Retinal Disease

When prescribing spectacle lenses, one of the most impactful things we can do is ask: “What are your visual goals?” or more simply, “What are you struggling to see clearly?”